[PDF] Top 20 Las exportaciones españolas de productos industriales en la década 1961 1971
Has 10000 "Las exportaciones españolas de productos industriales en la década 1961 1971" found on our website. Below are the top 20 most common "Las exportaciones españolas de productos industriales en la década 1961 1971".
DNMT3B -579G>T (rs1569686G>T) polymorphism and the risk of multiple sclerosis in a subset of Iranian population
... Environmental risk factors can exert their effects on gene expression and in consequence on phenotype through epigenetic ...environmental risk agents of MS on epigenetic mechanisms, existence of modified ... See full document
6
Association between rs1800795 ( 174 G/C) Polymorphism in the Promoter of IL6 Gene and Risk of Relapsing Remitting Multiple Sclerosis (RRMS) in Isfahan Population
... Multiple sclerosis (MS) is an inflammatory demyelinating disease of central nervous system (CNS) that mostly affects young ...nucleotide polymorphism (SNP) linked with autoimmune disorders ... See full document
256
RAGE p.82G>S Polymorphism Is Not Associated with the Risk of Multiple Sclerosis in Iranian Population
... As a member of the immunoglobulin superfamily of cell surface molecules, RAGE comprises one V-type domain, which binds diverse ligands, followed by two C-type immunoglobulin-like domains [21]. It has been shown that when ... See full document
23
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data
... -1a-treated population tends to consist predominantly of white females between 30 and 60 years of age (Biogen Idec, data on ...the risk over time are limited due to the fact that the duration of ... See full document
9
Risk Assessment: A Mandatory Evaluation and Analysis of Periodontal Tissue in General Population A Survey
... Majority of the subjects in low risk category had score 0 of attachment loss/ age ratio and thus shows that they are less likely to develop periodontitis. Preshaw et al[14] have demonstrated that refractory ... See full document
30
The genetics of multiple sclerosis: review of current and emerging candidates
... thresholds, multiple-testing corrected t-test, rank product, significance analysis of microarrays, linear models for microarray data, ...relieving multiple-testing stringency has been applied in ... See full document
21
Autoinjector preference in multiple sclerosis and the role of nurses in treatment decisions: results from an international survey in Europe and the USA
... Purpose: This international survey recorded the opinions of multiple sclerosis (MS) nurses about their role in treatment decision making and about the importance of different attribute[r] ... See full document
7
Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence
... including multiple sclerosis ...Keywords: multiple sclerosis, adherence, compliance, interruption, adverse events, efficacy, tolerability, ... See full document
24
Epstein Barr Virus—The Cause of Multiple Sclerosis
... of Multiple Sclerosis (MS) is largely unknown but Multiple Sclerosis (MS) is rare among individuals without serum EBV ...of Multiple Sclerosis ...tiple Sclerosis (MS) ... See full document
39
The spectrum of psychosis in multiple sclerosis: a clinical case series
... Abstract: Psychosis in the context of multiple sclerosis (MS) has previously been reported as a rare occurrence. However, recent epidemiological studies have found prevalence rates of psychosis in MS that ... See full document
156
Recent advances in the treatment of multiple sclerosis
... Studies of alemtuzumab in the treatment of patients with RRMS and secondary progressive MS (SPMS) have shown efficacy in the suppression of annualized relapse rate but with variable results in preventing progression of ... See full document
12
The X-ray Repair Cross-Complementing Group 1 Arg399Gln Genetic Polymorphism and Risk of Hepatocellular Carcinoma in an Iranian Population
... the risk of HCC develop- ment and also, the Gln/Gln genotype may increase the risk of HCC in Iranian ...gene polymorphism and HCC in Iranian ... See full document
8
New approaches in the management of multiple sclerosis
... autoreactive T cells and demyelinating antibodies from the systemic circulation into the CNS through disruption of the ...of T cells into the ...activated T cells, such as iFN-γ and TNF-β, may ... See full document
27
Quality of life in patients with multiple sclerosis: a pilot study
... A queste sono state aggiunte ulteriori correlazioni tra le sottoscale della scala salute fisica e mentale (Tab. II) e il punteggio totale della scala MFIS, per individuare qua- li dell[r] ... See full document
21
Development of a spirometry <em>T</em>-score in the general population
... 1 T-score appears to be superior in prediction performance of important ...spirometry T-score, should we use it in clinical practice? Without a consensus of experts or academic societies, we should be ... See full document
79
Assessing cost-effectiveness in the management of multiple sclerosis
... IFN β -1b intervention lasting 12 cycles (3 years) discounted at 3%. Mean total costs in the placebo arm amounted to € 399,200 with the intervention € 400,700. Cost per QALY gained was € 7,800 (after 12 cycles). However, ... See full document
11
Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies
... Food and Drug Administration approved the reintroduction of natalizumab for treating MS. Natalizumab belongs to a promising novel class of therapeutic agents for the treatment of relapsing MS. However because it is ... See full document
14
Incidence and risk of chondrolysis in Denmark: A nationwide population-based study
... and risk factors have not been studied in a formal epidemiologic population-based ...general population as the ...age-matched population controls were sampled for a case-control ...these ... See full document
5
ACTH gel in the treatment of multiple sclerosis exacerbation: a case study
... Abstract: Patients may refuse, be unable to use, or show nonresponse to conventional steroid treatment of multiple sclerosis (MS) exacerbation. Adrenocorticotropic hormone (ACTH), one of several ... See full document
10
Patient considerations in the management of multiple sclerosis: development and clinical utility of oral agents
... Abstract: Multiple sclerosis (MS) is one of the most frequently occurring disabling neurological disorders among young adults in ...MS population, and choices will become even more complex so that ... See full document
44
Related subjects